Keating Financial Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.8K Sell
381
-869
-70% -$70.1K ﹤0.01% 838
2026
Q1
$108K Sell
1,250
-154
-11% -$14.8K 0.02% 444
2025
Q4
$135K Buy
+1,404
New +$136K 0.02% 449

Other funds holding MDT

Keating Financial Advisory Services's MDT Position: Q2 2026 in Review

Keating Financial Advisory Services reduced its Medtronic (MDT) stake by 70% in Q2 2026, selling an estimated $70.1K and leaving 381 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #838.

Keating Financial Advisory Services first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $135K in Q4 2025. 2,131 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Keating Financial Advisory Services held 381 shares of Medtronic worth $29.8K as of Q2 2026.
  • Keating Financial Advisory Services sold 869 Medtronic shares in Q2 2026, an estimated $70.1K.
  • Medtronic made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q2 2026, its #838 holding.
  • Keating Financial Advisory Services first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • Keating Financial Advisory Services's Medtronic position peaked at $135K in Q4 2025.
  • 2,131 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Keating Financial Advisory Services's 13F filing for Q2 2026, filed 11 Aug 2026.